Does evidence support renin-angiotensin system blockade for slowing nephropathy progression in elderly persons?

Annals of Internal Medicine

Volumn 150, Issue 10, 2009, Pages

  Sarafidis, Pantelis A ^a   Bakris, George L ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PROTEIN;

ARTICLE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DISEASE COURSE; EVIDENCE BASED PRACTICE; GLOMERULUS FILTRATION RATE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; AGE; AGED; CHRONIC DISEASE; CLINICAL TRIAL; HUMAN; KIDNEY DISEASE; MIDDLE AGED; NOTE; PATIENT SELECTION; STANDARD;

AGE FACTORS; AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHRONIC DISEASE; CLINICAL TRIALS AS TOPIC; HUMANS; KIDNEY DISEASES; MIDDLE AGED; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC;

EID: 66149171758     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-150-10-200905190-00014     Document Type: Article

References (20)

1. Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004; 43(5 Suppl 1):1-290. [PMID: 15114537]
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252 [PMID: 14656957]
3. KDOQI. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49:S12- 154. [PMID: 17276798]
4. Sarafidis PA, Khosla N, Bakris GL. Antihypertensive therapy in the presence of proteinuria. Am J Kidney Dis. 2007;49:12-26. [PMID: 17185142]
5. Sarafidis PA, Stafylas PC, Kanaki AI, Lasaridis AN. Effects of reninangiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis. Am J Hypertens. 2008;21:922-929 [PMID: 18535536]
6. Khosla N, Bakris G. Lessons learned from recent hypertension trials about kidney disease. Clin J Am Soc Nephrol. 2006;1:229-235 [PMID: 17699211]
7. Lea J, Greene T, Hebert L, Lipkowitz M, Massry S, Middleton J, et al. The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension. Arch Intern Med. 2005;165:947-953 [PMID: 15851648] (Pubitemid 40563243)
8. Atkins RC, Briganti EM, Lewis JB, Hunsicker LG, Braden G, Champion de Crespigny PJ, et al. Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. Am J Kidney Dis. 2005;45:281-287 [PMID: 15685505] (Pubitemid 40431053)
9. Estacio RO, Jeffers BW, Gifford N, Schrier RW. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care. 2000;23 Suppl 2:B54-64. [PMID: 10860192] (Pubitemid 30185779)
10. Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT Jr, Whelton PK, et al. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med. 2005;165:936-946 [PMID: 15851647] (Pubitemid 40563242)
11. Casas JP, Chua W, Loukogeorgakis S, Vallance P, Smeeth L, Hingorani AD, et al. Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet. 2005;366:2026-2033 [PMID: 16338452] (Pubitemid 41773378)
12. U.S. Renal Data Service. Chapter 2: incidence and prevalence. In: USRDS 2008 Annual Data Report. Bethesda, MD: National Institutes of Health; 2008. Accessed at www.usrds.org/2008/slides/htm/vol2-02-incid-prev-08.swf on 10 April 2009.
13. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038-2047 [PMID: 17986697] (Pubitemid 350074801)
14. O'Hare AM, Kaufman JS, Covinsky KE, Landefeld CS, McFarland LV, Larson EB. Current guidelines for using angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease: is the evidence base relevant to older adults? Ann Intern Med. 2009;150:717-724
15. Jerums G, Panagiotopoulos S, Premaratne E, Power DA, MacIsaac RJ. Lowering of proteinuria in response to antihypertensive therapy predicts improved renal function in late but not in early diabetic nephropathy: a pooled analysis. Am J Nephrol. 2008;28:614-627 [PMID: 18285683]
16. So WY, Kong AP, Ma RC, Ozaki R, Szeto CC, Chan NN, et al. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diabetes Care. 2006;29:2046-2052 [PMID: 16936151]
17. Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247-254 [PMID: 16908915]
18. Winearls CG, Glassock RJ. Dissecting and refining the staging of chronic kidney disease. Kidney Int. 2009. [PMID: 19242501]
19. Zhou XJ, Rakheja D, Yu X, Saxena R, Vaziri ND, Silva FG. The aging kidney. Kidney Int. 2008;74:710-720 [PMID: 18614996]
20. Musso CG, Liakopoulos V, Ioannidis I, Eleftheriadis T, Stefanidis I. Acute renal failure in the elderly: particular characteristics. Int Urol Nephrol. 2006;38:787-793 [PMID: 17160631] (Pubitemid 46336043)